![]() The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. Novartis AG Swiss pharmaceutical giant Novartis is valued at roughly 200 billion at present, making it one of the top 10 health care firms globally. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. ![]() ![]() When was Novartiss most recent ex-dividend date Novartiss most recent ex-dividend date was Thursday, March 9, 2023. At nearly 16 times forward earnings, the drugmakers shares are modestly undervalued relative to big pharma stocks at large (average forward. Novartiss most recent annually dividend payment of 3.4694 per share was made to shareholders on Monday, March 20, 2023. Novartis AG is a Switzerland-based pharmaceutical company. The 18 analysts offering 12-month price forecasts for Novartis AG have a median target of 112.55, with a high estimate of 125.23 and a low estimate of 84.00. Quotes ADRs NVS Overview Sectors NVS U.S.: NYSE Novartis AG ADR Watch list Set a price target alert After Hours Last Updated: 4:00 p.m. Novartis stock trades at a fairly reasonable valuation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |